½ÃÀ庸°í¼­
»óǰÄÚµå
1560811

¼¼°èÀÇ ÀÚµ¿ ¾×ü ó¸®(ALH) ½ÃÀå(2024-2031³â)

Global Automated Liquid Handling Market - 2024 - 2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 176 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°³¿ä

¼¼°èÀÇ ÀÚµ¿ ¾×ü ó¸®(ALH) ½ÃÀåÀº 2023³â¿¡ 12¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2031³â¿¡´Â 23¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2024-2031³â CAGRÀº 8.5%·Î ¼ºÀåÇÒ Àü¸Á

ÀÚµ¿ ¾×ü ó¸®(ALH) ½ÃÀåÀº ½ÇÇè½Ç¿¡¼­ ¾×üÀÇ Á¤È®Çϰí È¿À²ÀûÀÎ À̼ÛÀ» ÀÚµ¿È­ÇÏ¿© ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ½Ç¼ö¸¦ ÁÙÀ̰í, 󸮷®À» Áõ°¡½Ã۸ç, ½ÇÇèÀÇ ¹Ýº¹¼ºÀ» Çâ»ó½ÃŰ´Â ±â¼ú°ú ½Ã½ºÅÛ¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº Á¤È®¼º°ú Àϰü¼ºÀÌ ÇʼöÀûÀÎ ½Å¾à°³¹ß, À¯Àüü, ÀÓ»óÁø´Ü, ´Ü¹éÁúüÇÐ ºÐ¾ß¿¡¼­ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ¹ßÀü, °í󸮷® ½ºÅ©¸®´×¿¡ ´ëÇÑ ¼ö¿ä, ¿öÅ©Ç÷οìÀÇ °£¼ÒÈ­°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ±â¼úÀº Àü ¼¼°è Á¦¾à»ç, Çмú±â°ü, Áø´Ü ½ÇÇè½Ç, À§Å¹ ¿¬±¸ ±â°ü¿¡ ÇʼöÀûÀÎ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ

ÅëÇÕ ¼Ö·ç¼ÇÀ¸·ÎÀÇ Àüȯ

À¯Àüü ºÐ¼®ÀÇ Ã³¸®·®¿¡ ´ëÇÑ ¿ä±¸¿Í º¹À⼺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÅëÇÕµÈ ¿ÃÀοø ÀÚµ¿È­ ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ Á¡Á¡ ´õ ºÐ¸íÇØÁö°í ÀÖ½À´Ï´Ù. ¿¬±¸½ÇÀº ÇöÀç NGS¿Í °°Àº À¯ÀüüÇÐ ºÐ¾ß»Ó¸¸ ¾Æ´Ï¶ó °í󸮷® ½Å¾à°³¹ßÀ̳ª ±¸Á¶»ý¹°ÇÐ °°Àº ´Ù¸¥ ºÐ¾ß¿¡¼­µµ Ư¼öÇÑ ¿öÅ©Ç÷ο쿡 ÀûÀÀÇÒ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. Á¾ÇÕÀûÀÎ ¾×ü Ãë±Þ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ÅëÇÕ ½Ã½ºÅÛÀ» ÅëÇØ ½ÇÇè½ÇÀº ½ÇÇè½Ç °ø°£À» Èñ»ýÇÏÁö ¾Ê°íµµ °úÇÐÀû ¹ß°ßÀÇ ÃÖÀü¼±¿¡ ¸Ó¹«¸¦ ¼ö ÀÖ½À´Ï´Ù.

Ãֽо×ü ó¸® ½Ã½ºÅÛ ¿î¿µÀÇ º¹À⼺

º¹ÀâÇÑ ¿öÅ©½ºÅ×ÀÌ¼Ç ¹× ALH ½Ã½ºÅÛÀº PCR ¼³Á¤, Ç÷¹ÀÌÆ® ÀçÆ÷¸Ë, Å©·Î¸¶Åä±×·¡ÇÇ ºÐ¼®°ú °°Àº ƯÁ¤ ÀÛ¾÷À» À§ÇØ ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº °íµµ·Î ÇÁ·Î±×·¡¹ÖÀÌ °¡´ÉÇÏ¸ç ½ÇÇè½Ç ÀÚµ¿È­ ½Ã½ºÅÛ¿¡ ÅëÇյǾî ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÷´Ü ±â¼úÀÌ ÇÊ¿äÇϰí ÀÎÀû ¿À·ùÀÇ ¿µÇâÀ» ¹Þ±â ½±½À´Ï´Ù. ¿À¿°Àº ƯÈ÷ ¾×ü Çڵ鷯 Çìµå¿Í °°Àº ÀÚµ¿È­ Àåºñ¸¦ ´Ù·ê ¶§ ƯÈ÷ ¹®Á¦°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. »ç¿ëÀÚ´Â ¿À¿°À» ÇÇÇϱâ À§ÇØ Ä¨°ú °øÁ¤À» Æò°¡ÇÏ°í ¹èÃâÀ» ½ÅÁßÇÏ°Ô °èÈ¹ÇØ¾ß ÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

¼¼°è ÀÚµ¿ ¾×ü ó¸®(ALH) ½ÃÀåÀº Á¦Ç° À¯Çü, ó¸®, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç° À¯Çüº° ÀÚµ¿ ÇÇÆêÆÃ ½Ã½ºÅÛÀº ÀÚµ¿ ¾×ü ó¸®(ALH) ½ÃÀå Á¡À¯À²ÀÇ ¾à 45.3%¸¦ Â÷ÁöÇÕ´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ÀÚµ¿ºÐÁֱⰡ ¾à 45.3%¸¦ Â÷ÁöÇÕ´Ï´Ù. ÀÚµ¿ ÇÇÆêÆÃ ½Ã½ºÅÛÀº ¾×ü Ãë±Þ¿¡ ÇʼöÀûÀ̸ç, ÀÎÀ§ÀûÀÎ ½Ç¼ö¸¦ ÁÙÀÌ°í ¾×ü ÃøÁ¤ÀÇ ³ôÀº Á¤È®µµ¸¦ º¸ÀåÇÕ´Ï´Ù. Á¤È®ÇÑ ½Ã¾à ¹× ½Ã·áÀÇ ºÐÁÖ°¡ Áß¿äÇÑ ½Å¾à °³¹ß, À¯Àüü, ºÐÀÚ»ý¹°ÇÐ ¹× ±âŸ ¿ëµµ¿¡¼­ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ´Ù¾çÇÑ ¿ë·®À» ó¸®ÇÒ ¼ö ÀÖÀ¸¸ç, ¿¬¼Ó Èñ¼®, È¥ÇÕ, Ç÷¹ÀÌÆ® ÃæÀü°ú °°Àº º¹ÀâÇÑ ±â¼úÀ» ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. 󸮷®À» ´Ã¸®°í º¯µ¿À» ÁÙÀÓÀ¸·Î½á ¿¬±¸ ¹× ÀÓ»ó ½ÇÇè½ÇÀÇ »ý»ê¼º°ú Àϰü¼ºÀ» ³ôÀ̰í, °úÇÐÀÚµéÀÌ ¼öµ¿À¸·Î ºÐÁÖÇÏ´Â ÀÛ¾÷º¸´Ù µ¥ÀÌÅÍ ºÐ¼®°ú ÇØ¼®¿¡ ÁýÁßÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ±× °á°ú, ÀÚµ¿ ºÐÁÖ±â´Â °úÇÐ ¿¬±¸¿Í Çõ½ÅÀ» ÃËÁøÇÏ´Â ½ÇÇè½ÇÀÇ ÇʼöÀûÀÎ Åø·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº° ½ÃÀå Á¡À¯À²

ºÏ¹Ì´Â ¿¹Ãø ±â°£ Áß Àüü ½ÃÀå Á¡À¯À²ÀÇ ¾à 38.4%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì¿¡´Â ´Ù¾çÇÑ Á¦¾à»ç ¹× ¹ÙÀÌ¿À Á¦¾à»ç°¡ Á¸ÀçÇÏ°í ¿¬±¸°³¹ßºñ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÃßÁ¤ ¹× ¿¹Ãø ±â°£ Áß Àüü ½ÃÀå Á¡À¯À²ÀÇ ¾à 38.4%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ºÏ¹Ì ½ÃÀå È®´ë¿¡ ÈûÀ» ½Ç¾îÁÙ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ °í󸮷® ½ºÅ©¸®´×°ú ÇÔ²² È¿À²ÀûÀ̰í Á¤È®ÇÑ Çڵ鸵 ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä·Î ÀÎÇØ ½ÃÀåµµ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î 2023³â 11¿ù ¾Æ¸Þ¸®°í »çÀ̾ðƼÇÈÀº ¹ÙÀÌ¿À¸ÞµðÄà ¹× »ý¸í°úÇÐ ºÐ¾ß¿¡ Áß¿äÇÑ Á¦Ç°°ú ¼­ºñ½º¸¦ Á¦°øÇÏ´Â µ¥ ÁÖ·ÂÇÏ´Â À¯Åë¾÷ü·Î¼­ °úÇаèÀÇ ÇÇÆêÆÃ ¿öÅ©Ç÷ο츦 Çö´ëÈ­Çϱâ À§ÇØ Çõ½ÅÀûÀÎ ÀÚµ¿ ¾×ü ó¸®(ALH) Àåºñ¸¦ Ãâ½ÃÇß½À´Ï´Ù. ¾×ü Ãë±Þ(ALH) Àåºñ¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÷´Ü ±â¼ú°ú ÃÖ÷´Ü ±â´ÉÀ» °®Ãá ÀÌ »õ·Î¿î ¼Ö·ç¼ÇÀº È¿À²¼º°ú Á¤È®¼ºÀ» ³ôÀÌ°í ¿¬±¸ÀÚ¿Í °úÇÐÀÚµéÀÇ ±ÍÁßÇÑ ½Ã°£À» Àý¾àÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÙ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ÅëÇÕ ¼Ö·ç¼Ç·ÎÀÇ À̵¿
    • ¾ïÁ¦¿äÀÎ
      • Ãֽо×ü ó¸® ½Ã½ºÅÛ Á¶ÀÛÀÇ º¹À⼺
    • ±âȸ
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ ºÐ¼®
  • ƯÇ㠺м®
  • PESTLE ºÐ¼®
  • SWOT ºÐ¼®
  • DMI Àǰß

Á¦6Àå Á¦Ç° À¯Çüº°

  • ÀÚµ¿ ÇÇÆêÆÃ ½Ã½ºÅÛ
  • ¼Ò¸ðǰ
  • ¿öÅ©½ºÅ×À̼Ç
  • ½Ã¾à

Á¦7Àå ½Ã¼úº°

  • Ç÷¹ÀÌÆ® ÀçÆ÷¸Ë
  • Ç÷¹ÀÌÆ® º¹Á¦
  • PCR ¼Â¾÷
  • High Throughput Screening
  • Àü°Ô³ð ÁõÆø
  • ¼¼Æ÷¹è¾ç
  • ±âŸ

Á¦8Àå ¾ÖÇø®ÄÉÀ̼Ǻ°

  • Drug Discovery¡¤ÀǾàǰ °³¹ß
  • À¯ÀüüÇÐ
  • ÀÓ»ó Áø´Ü
  • ´Ü¹éÁúüÇÐ
  • ±âŸ

Á¦9Àå ÃÖÁ¾»ç¿ëÀÚº°

  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦10Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • °æÀï ½Ã³ª¸®¿À
  • ½ÃÀå ÇöȲ/Á¡À¯À² ºÐ¼®
  • M&A ºÐ¼®

Á¦12Àå ±â¾÷ °³¿ä

  • Aurora Biomed Inc
    • ȸ»ç °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü
  • Hamilton Company
  • PerkinElmer Inc.
  • Agilent Technologies
  • Thermo Fisher Inc
  • Danaher Corporation
  • Tecan Group Limited
  • Eppendorf AG
  • Qiagen N.V
  • Corning Inc

Á¦13Àå ºÎ·Ï

KSA 24.10.11

Overview

Global Automated Liquid Handling Market reached US$ 1.2 billion in 2023 and is expected to reach US$ 2.3 billion by 2031, growing at a CAGR of 8.5% during the forecast period 2024-2031

The automated liquid handling market focuses on technologies and systems that automate the precise and efficient transfer of liquids in laboratories, reducing manual errors, enhancing throughput, and increasing experiment reproducibility. These systems are crucial in drug discovery, genomics, clinical diagnostics, and proteomics, where accuracy and consistency are essential.

The market is driven by biotechnology advancements, high-throughput screening demands, and workflow streamlining, these technologies are essential tools for pharmaceutical companies, academic institutions, diagnostic laboratories, and contract research organizations worldwide.

Market Dynamics: Drivers & Restraints

Moving towards integrated solutions

As the throughput demands and complexity of genomic assays continue to rise, the need for integrated, all-in-one automated solutions becomes increasingly apparent. Laboratories are now looking for systems that can adapt to specialized workflows in genomics, such as NGS, as well as in other fields, like high-throughput drug discovery and structural biology. Integrated systems that offer a comprehensive liquid handling solution will enable labs to stay at the forefront of scientific discovery without needing to sacrifice premium lab space.

Modern liquid handling systems operational complexity

Complex workstations and ALH systems are designed for specific tasks like PCR setup, plate reformatting, and chromatographic analysis. These systems are highly programmable and integrated into through-lab automation systems. However, they require strong skill sets and are susceptible to human error. Contamination is another issue, especially when handling automated equipment like liquid handler heads. Users should assess their tips and processes to avoid contamination and plan their ejecting carefully.

Market Segment Analysis

The global automated liquid handling market is segmented based on product type, procedure, application, end user, and region.

The automated pipetting systems from the product type segment accounted for approximately 45.3% of the Automated Liquid Handling market share

The automated pipetting systems from the product type segment accounted for approximately 45.3%. Automated pipetting systems are essential in liquid handling, reducing human error and ensuring high accuracy in liquid measurements. They are crucial in applications like drug discovery, genomics, and molecular biology, where accurate reagent and sample dispensing is critical. These systems can handle various volumes and perform complex techniques like serial dilutions, mixing, and plate filling. By increasing throughput and reducing variability, they enhance productivity and consistency in research and clinical labs, allowing scientists to focus on data analysis and interpretation rather than manual pipetting tasks. As a result, automated pipetting systems have become essential tools in laboratories, driving scientific research and innovation.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to the presence of various pharmaceutical and biopharmaceutical companies in the region, in addition to rising expenditures on R&D, which is anticipated to support the market expansion in North America. Furthermore, the market is also growing due to the demand for efficient and accurate handling systems along with high-throughput screening.

For instance, in November 2023, Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, launched its innovative automated liquid handling equipment, aimed at modernizing the pipetting workflow within the scientific community. With advanced technology and cutting-edge features, this new solution promises to boost efficiency and accuracy, saving valuable time for researchers and scientists.

Market Segmentation

By Product Type

Automated Pipetting Systems

Consumables

Workstations

Reagents

By Procedure

Plate Reformatting

Plate Replication

PCR setup

High Throughput screening

Whole Genome Amplification

Cell Culture

Others

By Application

Drug Discovery and Development

Genomics

Clinical Diagnostics

Proteomics

Others

By End User

Pharmaceutical and Biotechnology Companies

Research Organizations

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Aurora Biomed Inc., Hamilton Company, PerkinElmer Inc., Agilent Technologies, Thermo Fisher Inc., Danaher Corporation, Tecan Group Limited, Eppendorf AG, Qiagen N.V, Corning Inc. among others.

Key Developments

In November 2023, SPT Labtech introduced Firefly for LDT, a solution aimed at streamlining liquid handling in Next-Generation Sequencing (NGS)-based lab-developed tests (LDTs).

In July 2023, Revvity unveiled the Fontus Automated Liquid Handling Workstation, a cutting-edge liquid handler that integrates advanced technologies from Revvity's existing platforms. This workstation is specifically designed to enhance and expedite workflows for next-generation sequencing (NGS) and diagnostic research applications.

Why Purchase the Report?

To visualize the global automated liquid handling market segmentation based on product type, procedure, application, end user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the automated liquid handling market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global automated liquid handling market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Procedure
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Moving towards integrated solutions
    • 4.1.2. Restraints
      • 4.1.2.1. Modern liquid handling systems operational complexity
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis
  • 5.6. PESTLE Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Automated Pipetting Systems*
    • 6.2.1. Introduction
  • 6.3. Consumables
  • 6.4. Workstations
  • 6.5. Reagents

7. By Procedure

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
  • 7.2. Market Attractiveness Index, By Procedure
  • 7.3. Plate Reformatting*
    • 7.3.1. Introduction
    • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.4. Plate Replication
  • 7.5. PCR setup
  • 7.6. High Throughput screening
  • 7.7. Whole Genome Amplification
  • 7.8. Cell Culture
  • 7.9. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Drug Discovery and Development*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Genomics
  • 8.4. Clinical Diagnostics
  • 8.5. Proteomics
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Pharmaceutical and Biotechnology Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Research Organizations
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. UK
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Aurora Biomed Inc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Hamilton Company
  • 12.3. PerkinElmer Inc.
  • 12.4. Agilent Technologies
  • 12.5. Thermo Fisher Inc
  • 12.6. Danaher Corporation
  • 12.7. Tecan Group Limited
  • 12.8. Eppendorf AG
  • 12.9. Qiagen N.V
  • 12.10. Corning Inc (*LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦